Aller au contenu principal
Profil bibliographique

Claus Pfannenstiel

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

12Publications signalées
401Citations signalées
0Affiliations récentes

Les domaines associés

Cystic Fibrosis Research AdvancesAsthma and respiratory diseasesNeonatal Respiratory Health ResearchFood Allergy and Anaphylaxis ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Les publications récentes

Accès ouvert 2023 article OpenAlex

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry

Sivagurunathan Sutharsan, Stefanie Dillenhoefer, Matthias Welsner, Florian Stehling et autres

Treatment with elexacaftor/tezacaftor/ivacaftor (ETI) improves multiple clinical outcomes in people with cystic fibrosis (pwCF) with at least one F508del allele. This study evaluated the real-world impact of ETI on lung function, nutritional status, pulmonary exacerbation frequency, and sweat chloride concentrations in a …

de, at (code pays fourni par la source)

74 citations The Lancet Regional Health - Europe
Accès ouvert 2015 article OpenAlex

Genotype alone does not predict the clinical course ofSFTPCdeficiency in paediatric patients

Carolin I. Kröner, Simone Reu, Veronika I. Teusch, Andrea Schams et autres

Patients with interstitial lung disease due to surfactant protein C (SFTPC) mutations are rare and not well characterised. We report on all subjects collected over a 15-year period in the kids-lung register with interstitial lung disease and a proven SFTPC mutation. We …

de, nl, be, tr (code pays fourni par la source)

96 citations European Respiratory Journal
Accès ouvert 2014 article OpenAlex

Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

Sylvia Lehmann, Claus Pfannenstiel, Frank Friedrichs, Kristina Kröger et autres

BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a severe complication in patients with cystic fibrosis (CF), resulting in deterioration of lung function and impairment of overall prognosis. Standard therapy consists of high dosage, long-term corticosteroid treatment. This carries the risk of serious side …

de (code pays fourni par la source)

41 citations Therapeutic Advances in Respiratory Disease
2011 conference-abstract OpenAlex

Old and novel surfactant protein C (SP-C) mutations in children

Ann-Christin Grimmelt, Michael G. Barker, Frank E. Brasch, Monika Gappa et autres

Genetic variations of SP-C gene are known to cause interstitial lung disease. In previous studies 55 patients have been described focussing on the genetic abnormalities and clinical course. Here we report the data of children with SP-C mutations collected between 1998 and …

de (code pays fourni par la source)

0 citations European Respiratory Journal
2004 article OpenAlex

Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis

Michael G. Barker, Daniel Thoenes, Hiltrud Döhmen, Frank Friedrichs et autres

Venous thrombosis in children and young adults is frequently associated with predisposing conditions and with an indwelling catheter or totally implantable venous access device (TIVAD). These systems are commonly used for the delivery of antibiotic therapy in patients with cystic fibrosis (CF). …

de (code pays fourni par la source)

42 citations Pediatric Pulmonology
2004 article OpenAlex

Effect of DNase on exercise capacity in cystic fibrosis

Michael G. Barker, Egbert Franke, Martin Böhle, Claus Pfannenstiel et autres

DNase can reduce viscosity and facilitate expectoration of airway secretions in cystic fibrosis (CF) lung disease. We evaluated its effect on exercise performance in relation to resting pulmonary function. Fifteen sputum-producing CF patients (aged 9-28 years; FEV1 22-83% predicted) performed spirometry, body …

de (code pays fourni par la source)

4 citations Pediatric Pulmonology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.